1-5 of 5
David L. Schwartz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model

Maria K. Gule, Yunyun Chen, Daisuke Sano, Mitchell J. Frederick, Ge Zhou, Mei Zhao, Zvonimir L. Milas, Chad E. Galer, Ying C. Henderson, Samar A. Jasser, David L. Schwartz, James A. Bankson, Jeffrey N. Myers, Stephen Y. Lai
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2281–2291.
https://doi.org/10.1158/1078-0432.CCR-10-2762
Published: 14 April 2011
View article titled, Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model
Open the PDF for Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model in another window
Includes: Supplementary data
Journal Articles

DNA Repair Biomarker Profiling of Head and Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death following Radiotherapy

Benjamin J. Moeller, John S. Yordy, Michelle D. Williams, Uma Giri, Uma Raju, David P. Molkentine, Lauren A. Byers, John V. Heymach, Michael D. Story, J. Jack Lee, Erich M Sturgis, Randal S. Weber, Adam S. Garden, K. Kian Ang, David L. Schwartz
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (7): 2035–2043.
https://doi.org/10.1158/1078-0432.CCR-10-2641
Published: 31 March 2011
View article titled, DNA Repair Biomarker Profiling of Head and Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death following Radiotherapy
Open the PDF for DNA Repair Biomarker Profiling of Head and Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death following Radiotherapy in another window
Includes: Supplementary data
Journal Articles

Imaging Epidermal Growth Factor Receptor Expression In vivo: Pharmacokinetic and Biodistribution Characterization of a Bioconjugated Quantum Dot Nanoprobe

Parmeswaran Diagaradjane, Jacobo M. Orenstein-Cardona, Norman E. Colón-Casasnovas, Amit Deorukhkar, Shujun Shentu, Norihito Kuno, David L. Schwartz, Juri G. Gelovani, Sunil Krishnan
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (3): 731–741.
https://doi.org/10.1158/1078-0432.CCR-07-1958
Published: 01 February 2008
View article titled, Imaging Epidermal Growth Factor Receptor Expression <em>In vivo</em>: Pharmacokinetic and Biodistribution Characterization of a Bioconjugated Quantum Dot Nanoprobe
Open the PDF for Imaging Epidermal Growth Factor Receptor Expression <em>In vivo</em>: Pharmacokinetic and Biodistribution Characterization of a Bioconjugated Quantum Dot Nanoprobe in another window
Includes: Supplementary data
Journal Articles

Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer

Joseph G. Rajendran, David L. Schwartz, Janet O'Sullivan, Lanell M. Peterson, Patrick Ng, Jeffrey Scharnhorst, John R. Grierson, Kenneth A. Krohn
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (18): 5435–5441.
https://doi.org/10.1158/1078-0432.CCR-05-1773
Published: 25 September 2006
View article titled, Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer
Open the PDF for Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer in another window
Journal Articles

Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by [18F]Fluoromisonidazole and [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging

Joseph G. Rajendran, David A. Mankoff, Finbarr O’Sullivan, Lanell M. Peterson, David L. Schwartz, Ernest U. Conrad, Alexander M. Spence, Mark Muzi, D. Greg Farwell, Kenneth A. Krohn
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (7): 2245–2252.
https://doi.org/10.1158/1078-0432.CCR-0688-3
Published: 08 April 2004
View article titled, Hypoxia and Glucose Metabolism in Malignant Tumors: <subtitle>Evaluation by [<sup>18</sup>F]Fluoromisonidazole and [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography Imaging</subtitle>
Open the PDF for Hypoxia and Glucose Metabolism in Malignant Tumors: <subtitle>Evaluation by [<sup>18</sup>F]Fluoromisonidazole and [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography Imaging</subtitle> in another window